143 filings
Page 2 of 8
8-K
73r9wnb34kh1
21 Mar 23
Regulation FD Disclosure
8:30am
8-K
krzoqah3
9 Jan 23
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
8:05am
8-K
1e1av0hq0yr2cj9
14 Dec 22
Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate
8:05am
8-K
vka78mip
28 Nov 22
Selecta Biosciences Announces Appointment of Blaine Davis as Chief Financial Officer
8:08am
8-K
hyralp5
18 Nov 22
November 2022 Selecta Biosciences Corporate Presentation SELB
4:30pm
8-K
qtzr9sk08c7v s0
3 Nov 22
Selecta Biosciences Reports Third Quarter 2022 Financial Results
8:00am
8-K
0nc8dml1qwrtju2
22 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
quz607l dpety
4 Aug 22
August 2022 Selecta Biosciences Corporate Presentation SELB
8:05am
8-K
kq2h9 x6fmx8
4 Aug 22
Selecta Biosciences Reports Second Quarter 2022 Financial Results
8:00am
8-K
w86ri 1fc8lq1xmdx1
30 Jun 22
Other Events
8:16am
8-K
4krcppzu4lf8
22 Jun 22
Other Events
4:15pm
8-K
mktuqqorhrsj7d0yl
21 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
g0p5q
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
vtqkq7o6og f3
13 Jun 22
Selecta Biosciences Announces Partnership Advancements
8:00am
8-K
o2yr fimdou05hzsg2c0
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
hkjgvlf4 erdgpbwq
18 May 22
In the Court of Chancery of the State of Delaware
8:00am
8-K
dwb duzk0ep
5 May 22
Selecta Biosciences Reports First Quarter 2022 Financial Results
8:00am
8-K
rb34u3dx5 j6
13 Apr 22
April 2022 Selecta Biosciences Corporate Presentation SELB
7:00am
8-K
ygagf8p
7 Apr 22
Selecta Biosciences Announces $38.7 Million Underwritten Offering
6:18am
8-K
137pe4 78ngvmlec
6 Apr 22
Other Events
4:11pm